Status:
COMPLETED
Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)
Lead Sponsor:
Organon and Co
Conditions:
Hypertension
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
This study will evaluate the bioequivalence of the losartan/hydrochlorothiazide (HCTZ) combination tablet and coadministration of losartan and hydrochlorothiazide.
Eligibility Criteria
Inclusion
- Subject is a healthy male or female between the ages of 18 and 45 years of age
- Subject does not smoke
Exclusion
- Subject has a history of any illness that might pose additional risk to participation or confound the results of the study
- Subject has a history of hepatitis B or C or significant drug allergies
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2004
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT00953680
Start Date
April 1 2004
End Date
July 1 2004
Last Update
February 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.